Scientists say a pill could help you live to 150? Here’s what’s actually known

A Shenzhen startup, Lonvi Biosciences, has publicly claimed that a grape‑seed–derived compound, procyanidin C1 (PCC1), could help people live to 150, citing mouse data and positioning China’s fast‑growing longevity sector as a global leader. Media reports attribute quotes like “living to 150 is definitely realistic” to Lonvi’s CTO and note state‑level interest in aging research.NYT coverage

What the science shows today

• PCC1 is a real compound with peer‑reviewed animal data. In a 2021 Nature Metabolism paper, intermittent PCC1 reduced senescent cells, improved late‑life function, and modestly extended mouse lifespan (around 9–10% in one cohort), acting as a senomorphic at low doses and senolytic at higher doses.Nature Metabolism original paperPubMed recordOSTI entry
• Follow‑on and related senolytic research in animals continues to suggest that targeting senescent cells can improve healthspan and sometimes lifespan, but human evidence is still preliminary and mostly limited to small or disease‑specific trials with other senolytics (for example, dasatinib+quercetin or fisetin), not PCC1.Nature review examples and related senolytic studies

What’s claim vs. fact about “150 years”

• Claim: Lonvi’s PCC1 pill could enable lifespans of 150 years “in a few years,” per widely cited interviews and re‑reports.NYT coverage Secondary outlets amplified the “150” headline and tied it to China’s broader longevity push.Financial ExpressJerusalem Post
• Fact: The “150 years” projection is a company statement, not a peer‑reviewed finding. No human clinical trials demonstrating life‑extension with PCC1 have been published. The best‑quality evidence remains mouse studies showing modest median lifespan extension and improved late‑life function, not extreme longevity.Nature Metabolism

Why the idea attracts attention

• Biological rationale: Senescent “zombie” cells accumulate with age and secrete inflammatory factors (SASP). Clearing or calming them (senolytics/senomorphics) is a credible geroscience strategy supported by animal data.Nature Metabolism
• National context: China has prioritized advanced biomedicine and aging research; media reports detail growing investment and a wave of longevity startups.NYT coverage

Bottom line

• PCC1 is scientifically interesting, with legit mouse data for healthspan and modest lifespan gains. But there is no human evidence that any pill—PCC1 included—can extend life to 150. Treat “150 in a few years” as marketing, not medicine, until rigorous human trials show safety, efficacy, and clinically meaningful benefits.Nature MetabolismPubMedNYT

---